Kinetics and Protein‐Inhibitor Docking Studies of Enantiomers of exo‐2‐Norbornyl‐N‐n‐butylcarbamates as Pseudomonas Lipase Inhibitors to Probe the Enantioselectivity of the Enzyme

Abstract

The Pseudomonas species lipase inhibition shows enantioselectivity for R-enantiomer over S-enantiomer of exo-2-norbornyl-N-n-butylcarbamates. R-, S-, and racemic-exo-2-norbornyl-N-n-butylcarbamates are all characterized as pseudo substrate inhibitors of the enzyme. Thus, the mechanism for Pseudomonas species lipase-catalyzed hydrolysis of the inhibitor is formation of the first enzyme-inhibitor Michaelis complex via nucleophilic attack of the active site serine to the inhibitor (K(i) step) then formation of the butylcarbamyl enzyme intermediate from this complex (k(2) step). Comparison of bimolecular rate constants (k(i) = k(2) / K(i)) of the inhibitors indicates that R-enantiomer is 1.8 times more potent than S-enantiomer. Thus, Pseudomonas species lipase shows enantioselectivity of 1.8 for R-exo-2-norbornyl-N-n-butylcarbamate over S-exo-2-norbornyl-N-n-butylcarbamate. Protein-ligand interaction studies on both enantiomers of exo-2-norbornyl-N-n-butylcarbamate as inhibitors of Pseudomonas species lipase using AutoDock suggest that R-enantiomer binds more tightly into the active site of the enzyme than S-enantiomer. The norbornyl ring of S-exo-2-norbornyl-N-n-butylcarbamate is repulsive to Ser 82 and His 251 of the catalytic triad as well as to Met 16 of the oxyanion hole. These repulsions may create few unfavorable interactions between S-exo-2-norbornyl-N-n-butylcarbamate and the enzyme and make this inhibitor a less potent one